source
- FDA holds psychedelic forum as Definium reports third successful Phase 3 trial of oral LSD for anxietyThe FDA convened a public forum on Monday to discuss the near‑term outlook for psychedelic drug development, highlighting interest from companies such as Compass Pathways and Definium Therapeutics.…
- FDA delays AstraZeneca breast cancer drug camizestrant PDUFA dateThe U.S. Food and Drug Administration has extended the PDUFA target date for AstraZeneca’s breast cancer candidate camizestrant, pushing the review timeline back by a few days. No new deadline was…